Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases DOI Open Access
Yufei Chen, Xueting Li, Siyuan Wang

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(3), P. 591 - 591

Published: Jan. 23, 2023

Iron functions as an essential micronutrient and participates in normal physiological biochemical processes the cardiovascular system. Ferroptosis is a novel type of iron-dependent cell death driven by iron accumulation lipid peroxidation, characterized depletion glutathione suppression peroxidase 4 (GPX4). Dysregulation metabolism ferroptosis have been implicated occurrence development diseases (CVDs), including hypertension, atherosclerosis, pulmonary myocardial ischemia/reperfusion injury, cardiomyopathy, heart failure. chelators deferoxamine dexrazoxane, lipophilic antioxidants ferrostatin-1 liproxstatin-1 revealed to abolish suppress peroxidation other CVDs. Notably, inhibition has demonstrated alleviate cardiac impairments, fibrosis pathological remodeling during hypertension potentiating GPX4 signaling. Administration improved injury inhibiting peroxidation. Several small molecules may be effective treatment ferroptosis-mediated In this article, we summarize regulatory roles underlying mechanisms dysregulation Targeting are potential therapeutic strategies prevention

Language: Английский

Resistance Exercise Training as a Primary Countermeasure to Age-Related Chronic Disease DOI Creative Commons
Jonathan C. Mcleod, Tanner Stokes, Stuart M. Phillips

et al.

Frontiers in Physiology, Journal Year: 2019, Volume and Issue: 10

Published: June 6, 2019

Age is a primary risk factor for number of chronic diseases including mobility disability, cardiovascular disease (CVD), type 2 diabetes (T2D), and cancer. Most physical activity guidelines emphasize the performance 150 min moderate-to-vigorous or 75 minutes vigorous aerobic exercise training (AET) weekly reduction risk. Nonetheless, there an emerging body evidence showing that resistance (RET) appears to be as effective AET in reducing several diseases. It may also RET more than some regards; converse likely true. We posit perceived divergent mode-dependent health benefits are small most cases. In this short review, our aim examine associations between (mobility T2D, CVD, cancer). postulate on how influencing it critical component healthy aging. Accumulating points potent robust preventive strategy against traditionally associated with AET, but favours countermeasure declines mobility. On basis review we propose promotion should assume prominent position particularly older persons.

Language: Английский

Citations

212

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries DOI Creative Commons
Ofri Mosenzon, Abdullah Alguwaihes,

Jose Luis Arenas Leon

et al.

Cardiovascular Diabetology, Journal Year: 2021, Volume and Issue: 20(1)

Published: July 27, 2021

Abstract Background There is a paucity of global data on cardiovascular disease (CVD) prevalence in people with type 2 diabetes (T2D). The primary objective the CAPTURE study was to estimate established CVD and its management adults T2D across 13 countries from five continents. Additional objectives were further characterize sample regarding demographics, clinical parameters medication usage, particular reference blood glucose-lowering agents (GLAs: glucagon-like peptide-1 receptor agonists sodium-glucose co-transporter-2 inhibitors) demonstrated benefit randomized intervention trials. Methods Data collected managed or specialist care Australia, China, Japan, Czech Republic, France, Hungary, Italy, Argentina, Brazil, Mexico, Israel, Kingdom Saudi Arabia, Turkey 2019, using standardized methodology. prevalence, weighted by each country, estimated for overall participating countries. Country-specific odds ratios adjusted relevant demographic parameters. Results included 9823 (n = 4502 care; n 5321 care). had median (interquartile range) duration 10.7 years (5.6–17.9 years) glycated hemoglobin 7.3% (6.6–8.4%) [56 mmol/mol (49–68 mmol/mol)]. Overall atherosclerotic estimates 34.8% (95% confidence interval [CI] 32.7–36.8) 31.8% CI 29.7–33.8%), respectively. Age, gender, accounted some between-country variation prevalence. GLAs used 21.9% participants, which similar participants without CVD: 21.5% 22.2%, Conclusions In approximately one three diagnosed CVD. low use even suggested that most not according contemporary cardiology guidelines. Study registration NCT03786406 (registered December 20, 2018), NCT03811288 January 18, 2019).

Language: Английский

Citations

176

Mediterranean Diet and Cardiovascular Disease Prevention: What Do We Know? DOI
Jordi Salas‐Salvadó, Nerea Becerra‐Tomás, Jesús García‐Gavilán

et al.

Progress in Cardiovascular Diseases, Journal Year: 2018, Volume and Issue: 61(1), P. 62 - 67

Published: April 18, 2018

Language: Английский

Citations

174

The health digital twin to tackle cardiovascular disease—a review of an emerging interdisciplinary field DOI Creative Commons
Genevieve Coorey, Gemma A. Figtree, David F. Fletcher

et al.

npj Digital Medicine, Journal Year: 2022, Volume and Issue: 5(1)

Published: Aug. 26, 2022

Potential benefits of precision medicine in cardiovascular disease (CVD) include more accurate phenotyping individual patients with the same condition or presentation, using multiple clinical, imaging, molecular and other variables to guide diagnosis treatment. An approach realising this potential is digital twin concept, whereby a virtual representation patient constructed receives real-time updates range data order predict optimise treatment selection for real-life patient. We explored term twin, its defining concepts, challenges as an emerging field, potentially important applications CVD. A mapping review was undertaken systematic search peer-reviewed literature. Industry-based participants patent were identified through web-based sources. Searches Compendex, EMBASE, Medline, ProQuest Scopus databases yielded 88 papers related conditions (28%, n = 25), non-cardiovascular (41%, 36), general aspects health (31%, 27). Fifteen companies commercial interest simulation modelling had products focused on The 18 from 11 applicants, which 73% 27% universities. Three applicants cardiac-related inventions. For CVD, research within industry academia recent, interdisciplinary, established globally. Overall, numerical models, although precursor models exist cyber-physical system characteristic true twin. Implementation ethical constraints clinical barriers adoption decision tools derived artificial intelligence systems.

Language: Английский

Citations

167

IoT-Cloud-Based Smart Healthcare Monitoring System for Heart Disease Prediction via Deep Learning DOI Open Access

A Angel Nancy,

D. Ravindran,

P. M. Durai Raj Vincent

et al.

Electronics, Journal Year: 2022, Volume and Issue: 11(15), P. 2292 - 2292

Published: July 22, 2022

The Internet of Things confers seamless connectivity between people and objects, its confluence with the Cloud improves our lives. Predictive analytics in medical domain can help turn a reactive healthcare strategy into proactive one, advanced artificial intelligence machine learning approaches permeating industry. As subfield ML, deep possesses transformative potential for accurately analysing vast data at exceptional speeds, eliciting intelligent insights, efficiently solving intricate issues. accurate timely prediction diseases is crucial ensuring preventive care alongside early intervention risk. With widespread adoption electronic clinical records, creating models enhanced accuracy key to harnessing recurrent neural network variants possessing ability manage sequential time-series data. proposed system acquires from IoT devices, stored on cloud pertaining patient history are subjected predictive analytics. smart monitoring predicting heart disease risk built around Bi-LSTM (bidirectional long short-term memory) showcases an 98.86%, precision 98.9%, sensitivity 98.8%, specificity 98.89%, F-measure which much better than existing systems.

Language: Английский

Citations

165

HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis DOI

Zhijun Meng,

Hongping Liang, Jianli Zhao

et al.

Life Sciences, Journal Year: 2021, Volume and Issue: 284, P. 119935 - 119935

Published: Sept. 8, 2021

Language: Английский

Citations

142

Association between metabolic syndrome and periodontitis: The role of lipids, inflammatory cytokines, altered host response, and the microbiome DOI Creative Commons
Flávia Q. Pirih,

Sepehr Monajemzadeh,

Neelima Singh

et al.

Periodontology 2000, Journal Year: 2021, Volume and Issue: 87(1), P. 50 - 75

Published: Aug. 31, 2021

Abstract Periodontitis has been associated with many systemic diseases and conditions, including metabolic syndrome. Metabolic syndrome is a cluster of conditions that occur concomitantly together they increase the risk cardiovascular disease double type 2 diabetes. In this review, we focus on association between periodontitis; however, also include information diabetes mellitus disease, since these two are significantly intertwined With regard to periodontitis syndrome, date, vast majority studies point an demonstrate can contribute development of, or worsen, Evaluating effect salivary microbiome, data presented herein support hypothesis bacterial profile altered in patients compared healthy patients. Considering three human animal diabetes, disease. Moreover, there evidence suggest alter oral microbiome. However, more needed fully understand influence have each other.

Language: Английский

Citations

131

The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease DOI Creative Commons
Leonard A. Kaminsky, Charles German, Mary T. Imboden

et al.

Progress in Cardiovascular Diseases, Journal Year: 2021, Volume and Issue: 70, P. 8 - 15

Published: Dec. 16, 2021

Cardiovascular disease (CVD) is the leading cause of death globally. Advancements in treatment CVD have reduced mortality rates, yet global burden remains high. Considering that still largely a preventable disease, prioritizing preventative measures through healthy lifestyle (HL) behaviors necessary to lessen CVD. HL behaviors, such as regular exercise, eating habits, adequate sleep, and smoking cessation, can influence number traditional risk factors well less commonly measured factor, cardiorespiratory fitness (CRF). It important note cardiac rehabilitation programs, which traditionally focused on secondary prevention, also emphasize importance making comprehensive behavior changes. This review discusses reduce an increased uptake assessment behaviors. An overview CRF factor discussed along with how improve other interventions. The role clinician for promoting prevent reviewed.

Language: Английский

Citations

131

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis DOI
Philip Joseph, Gholamreza Roshandel,

Peggy Gao

et al.

The Lancet, Journal Year: 2021, Volume and Issue: 398(10306), P. 1133 - 1146

Published: Aug. 29, 2021

Language: Английский

Citations

127

Green space and cardiovascular disease: A systematic review with meta-analysis DOI
Xiaoxuan Liu,

Xinli Ma,

Wenzhong Huang

et al.

Environmental Pollution, Journal Year: 2022, Volume and Issue: 301, P. 118990 - 118990

Published: Feb. 15, 2022

Language: Английский

Citations

124